HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers.

Abstract
Given that high-risk human papillomavirus (HPV) is the necessary cause of virtually all cervical cancer, the clinical meaning of HPV-negative cervical precancer is unknown. We, therefore, conducted a literature search in Ovid MEDLINE, PubMed Central, and Google Scholar to identify English-language studies in which (i) HPV-negative and -positive, histologically confirmed cervical intraepithelial neoplasia grade 2 or more severe diagnoses (CIN2+) were detected and (ii) summarized statistics or deidentified individual data were available to summarize proportions of biomarkers indicating risk of cancer. Nineteen studies including 3,089 (91.0%) HPV-positive and 307 (9.0%) HPV-negative CIN2+ were analyzed. HPV-positive CIN2+ (vs. HPV-negative CIN2+) was more likely to test positive for biomarkers linked to cancer risk: a study diagnosis of CIN3+ (vs. CIN2; 18 studies; 0.56 vs. 0.24; P < 0.001) preceding high-grade squamous intraepithelial lesion cytology (15 studies; 0.54 vs. 0.10; P < 0.001); and high-grade colposcopic impression (13 studies; 0.30 vs. 0.18; P = 0.03). HPV-negative CIN2+ was more likely to test positive for low-risk HPV genotypes than HPV-positive CIN2+ (P < 0.001). HPV-negative CIN2+ appears to have lower cancer risk than HPV-positive CIN2+. Clinical studies of human high-risk HPV testing for screening to prevent cervical cancer may refer samples of HPV test-negative women for disease ascertainment to correct verification bias in the estimates of clinical performance. However, verification bias adjustment of the clinical performance of HPV testing may overcorrect/underestimate its clinical performance to detect truly precancerous abnormalities.
AuthorsPhilip E Castle, Amanda J Pierz, Rachael Adcock, Shagufta Aslam, Partha S Basu, Jerome L Belinson, Jack Cuzick, Mariam El-Zein, Catterina Ferreccio, Cynthia Firnhaber, Eduardo L Franco, Patti E Gravitt, Sandra D Isidean, John Lin, Salaheddin M Mahmud, Joseph Monsonego, Richard Muwonge, Samuel Ratnam, Mahboobeh Safaeian, Mark Schiffman, Jennifer S Smith, Avril Swarts, Thomas C Wright, Vanessa Van De Wyngard, Long Fu Xi
JournalCancer prevention research (Philadelphia, Pa.) (Cancer Prev Res (Phila)) Vol. 13 Issue 10 Pg. 829-840 (10 2020) ISSN: 1940-6215 [Electronic] United States
PMID32655005 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2020 American Association for Cancer Research.
Topics
  • Adult
  • Early Detection of Cancer (methods)
  • Female
  • Global Health
  • Humans
  • Meta-Analysis as Topic
  • Papillomaviridae (isolation & purification)
  • Papillomavirus Infections (complications, virology)
  • Precancerous Conditions (diagnosis, epidemiology, virology)
  • Prognosis
  • Uterine Cervical Neoplasms (diagnosis, epidemiology, virology)
  • Uterine Cervical Dysplasia (diagnosis, epidemiology, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: